Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01721603
Title A Phase 2 Prospective Trial of Dabrafenib With Stereotactic Radiosurgery in BRAFV600E Melanoma Brain Metastases
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of California, San Francisco
Indications

melanoma

Therapies

Dabrafenib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of San Francisco, California San Francisco California 94115 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field